---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-088220"
form_type: "8-K"
ticker: "CLDX"
cik: "0000744218"
company_name: "Celldex Therapeutics, Inc."
filed_at: "2021-07-01T23:59:59+00:00"
generated_at: "2026-06-30T08:16:29.707874+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Celldex enters amended employment agreements with 10 executives, new salaries and bonus targets

## Summary
- CEO Marucci base salary $680,908 (60% bonus); CFO Martin $412,820 (40% bonus).
- Initial term through Dec 31, 2021, auto-renew yearly unless 90-day notice.
- Severance: 200% base salary lump sum on termination w/o cause or for good reason, plus 18 months COBRA.
- 25% of unvested equity vests immediately on such termination.
- Agreements standardize language; prior agreements restated effective July 1, 2021.

## SEC filing metadata
- accession: 0001104659-21-088220
- form_type: 8-K
- ticker: CLDX
- cik: 0000744218
- company_name: Celldex Therapeutics, Inc.
- filed_at: 2021-07-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744218/000110465921088220/0001104659-21-088220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744218/000110465921088220/tm2120284d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-088220
- JSON: https://secwatch.observer/filing/0001104659-21-088220.json
- Plain text: https://secwatch.observer/filing/0001104659-21-088220.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.